Evidence map›Paper›PMID 42151708›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2026

[Screening of the anti-

Zejun Guo, Xiangyu Xi, Xiaoming Zhong, Fengmei Qiu, Zhen Huang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zejun GuoSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. 1415699198@qq.com.
Xiangyu XiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xiaoming ZhongSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Fengmei QiuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhen HuangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. huangzhen@zcmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo screen Chinese herbal medicines for optimal inhibitory activity against

methodsThe Chinese herbal extract and its polar fractions exhibiting the strongest inhibitory effect against

resultsAmong the extracts of 20 Chinese herbal medicines, the extract of

conclusions

Indexed as

Antifungal AgentsDermatitis, SeborrheicDrugs, Chinese HerbalMalasseziaRosaCell LineHumansInterleukin-6KeratinocytesAntifungal AgentsDrugs, Chinese HerbalInterleukin-6Antifungal agentMalassezia furfurMechanismRosa chinensis Jacq.Seborrheic dermatitis

Identifiers

PMID42151708
PMCPMC13195742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.